\-\ Texto\\:\\ \ \(0\)\
\-\ profound\\ executive\\ dysfunction\ \(1\)\
\-\ mri\\:\\ axial\\ t2\\ fast\\ spin\\ echo\\ images\\ demonstrate\\ moderate\\ amount\\ of\\ periventricular\\ subcortical\\ and\\ deep\\ white\\ matter\\ hyperintensity\\ which\\ is\\ nonspecific\\.in\\ addition\\ there\\ is\\ moderate\\ atrophy\\ of\\ the\\ bilateral\\ cerebral\\ hemispheres\\.\\ \ \(0\)\
\-\ f\\-18\\ fdg\\ pet\\:\\ marked\\ hypometabolism\\ w\\/in\\ the\\ bilateral\\ temporoparietal\\ region\\.\ \(0\)\
\-\ alzheimer\\'s\\ disease\ \(0\)\
\-\ alzhiemer\\'s\\ disease\ \(0\)\
\-\ multiinfarct\\ dementia\ \(0\)\
\-\ diffuse\\ lewy\\ body\\ disease\\ \ \(0\)\
\-\ metabolic\\ or\\ infectious\\ eg\\ hiv\\ dementia\\ complex\ \(0\)\
\-\ pick\\â\\€\\™s\\ disease\\ \ \(0\)\
\-\ non\\ organic\\ basis\\ for\\ cognitive\\ dysfunction\ \(0\)\
\-\ 71\\ yo\\ male\\ patient\\ with\\ profound\\ executive\\ dysfunction\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ executive\\:\\ 0\\.3396290987178116\ \(0\)\
\-\ dysfunction\\:\\ 0\\.32371126216830953\ \(0\)\
\-\ profound\\:\\ 0\\.2744085468625117\ \(0\)\
\-\ dementia\\:\\ 0\\.2602692220219346\ \(0\)\
\-\ disease\\:\\ 0\\.18658555782221883\ \(0\)\
\-\ alzhiemer\\:\\ 0\\.17771330395859264\ \(0\)\
\-\ multiinfarct\\:\\ 0\\.17771330395859264\ \(0\)\
\-\ lewy\\:\\ 0\\.1698145493589058\ \(0\)\
\-\ moderate\\:\\ 0\\.16684374132419294\ \(0\)\
\-\ temporoparietal\\:\\ 0\\.15631153918312685\ \(0\)\
\-\ hypometabolism\\:\\ 0\\.1533085720548047\ \(0\)\
\-\ organic\\:\\ 0\\.1533085720548047\ \(0\)\
\-\ pick\\:\\ 0\\.15070728360703478\ \(0\)\
\-\ alzheimer\\:\\ 0\\.14841278458343998\ \(0\)\
\-\ cognitive\\:\\ 0\\.1285102767489895\ \(0\)\
\-\ spin\\:\\ 0\\.1249585204904358\ \(0\)\
\-\ fast\\:\\ 0\\.12252025162007105\ \(0\)\
\-\ fdg\\:\\ 0\\.1203534955185926\ \(0\)\
\-\ subcortical\\:\\ 0\\.11984747418999007\ \(0\)\
\-\ bilateral\\:\\ 0\\.11944551052008404\ \(0\)\
\-\ basis\\:\\ 0\\.11887323489874878\ \(0\)\
\-\ eg\\:\\ 0\\.11840379710355994\ \(0\)\
\-\ periventricular\\:\\ 0\\.11424321861389801\ \(0\)\
\-\ hyperintensity\\:\\ 0\\.11081674076663223\ \(0\)\
\-\ hiv\\:\\ 0\\.10989622027276483\ \(0\)\
\-\ hemispheres\\:\\ 0\\.1079037540561032\ \(0\)\
\-\ 71\\:\\ 0\\.1079037540561032\ \(0\)\
\-\ atrophy\\:\\ 0\\.1051340918219021\ \(0\)\
\-\ echo\\:\\ 0\\.10291798616694535\ \(0\)\
\-\ pet\\:\\ 0\\.10291798616694535\ \(0\)\
\-\ metabolic\\:\\ 0\\.10074020843811907\ \(0\)\
\-\ addition\\:\\ 0\\.08994581880431327\ \(0\)\
\-\ infectious\\:\\ 0\\.08941497599116642\ \(0\)\
\-\ amount\\:\\ 0\\.08889821556316421\ \(0\)\
\-\ deep\\:\\ 0\\.08650198928063738\ \(0\)\
\-\ complex\\:\\ 0\\.08562035802846696\ \(0\)\
\-\ matter\\:\\ 0\\.08461250954050413\ \(0\)\
\-\ marked\\:\\ 0\\.08404781128254672\ \(0\)\
\-\ cerebral\\:\\ 0\\.07698852290660609\ \(0\)\
\-\ white\\:\\ 0\\.07331722441046787\ \(0\)\
\-\ body\\:\\ 0\\.07313473384111926\ \(0\)\
\-\ diffuse\\:\\ 0\\.06968922255236117\ \(0\)\
\-\ yo\\:\\ 0\\.06942468874799379\ \(0\)\
\-\ region\\:\\ 0\\.06647004093130071\ \(0\)\
\-\ axial\\:\\ 0\\.06418988178749782\ \(0\)\
\-\ t2\\:\\ 0\\.06393336523204284\ \(0\)\
\-\ is\\:\\ 0\\.06086475362949509\ \(0\)\
\-\ demonstrate\\:\\ 0\\.05777088447524767\ \(0\)\
\-\ mri\\:\\ 0\\.057041790930988844\ \(0\)\
\-\ non\\:\\ 0\\.05272662384827395\ \(0\)\
\-\ images\\:\\ 0\\.05140277936741225\ \(0\)\
\-\ which\\:\\ 0\\.05052971052170452\ \(0\)\
\-\ male\\:\\ 0\\.04947719076463731\ \(0\)\
\-\ the\\:\\ 0\\.044346987290701696\ \(0\)\
\-\ there\\:\\ 0\\.04421635158808738\ \(0\)\
\-\ of\\:\\ 0\\.04349339927189774\ \(0\)\
\-\ or\\:\\ 0\\.03865846031587462\ \(0\)\
\-\ patient\\:\\ 0\\.036143432095007366\ \(0\)\
\-\ for\\:\\ 0\\.03368117956409685\ \(0\)\
\-\ and\\:\\ 0\\.022962651371657924\ \(0\)\
\-\ with\\:\\ 0\\.021759693283799397\ \(0\)\
